In summary, our study describes a novel interaction between CCL23 and CXCL10 in the tumor microenvironment, which is also associated clinical findings, indicating reduced overall survival with higher CCL23 and lower CXCL10 levels in human ovarian ascites. This evidence concerns the gene CXCL10 and neoplasm.